O Mayer Selected Research

O Mayer Research Topics

3	Coronary Disease (Coronary Heart Disease) 01/2017 - 10/2004
3	Insulin Resistance 01/2017 - 03/2000
3	Vascular Diseases (Vascular Disease) 08/2016 - 04/2003
3	Hypertension (High Blood Pressure) 04/2006 - 07/2001
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 01/2002
2	Stroke (Strokes) 06/2015 - 04/2003
2	Heart Failure 01/2008 - 01/2005
2	Infections 08/2003 - 04/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 04/2003 - 07/2001
1	Dyslipidemias (Dyslipidemia) 01/2017
1	Hypertriglyceridemic Waist 01/2017
1	Hypertriglyceridemia 08/2016
1	Vascular Calcification 01/2016
1	Sepsis (Septicemia) 04/2011
1	Necrotizing Enterocolitis 04/2011
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2010
1	Venous Thromboembolism 06/2010
1	Lung Neoplasms (Lung Cancer) 06/2010
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 06/2010
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2009
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2009
1	Overweight 04/2006
1	Hyperlipidemias (Hyperlipidemia) 10/2004
1	Pulmonary Embolism 08/2003
1	Embolism (Embolus) 08/2003
1	Renal Insufficiency (Renal Failure) 08/2003
1	Venous Thrombosis (Deep-Vein Thrombosis) 08/2003
1	Chronic Kidney Failure (Chronic Renal Failure) 04/2003
1	Myocardial Infarction 04/2003
1	Atherosclerosis 10/2001
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 10/2001
1	Hyperlipoproteinemias 03/2001

6	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 03/2000
4	LipidsIBA 01/2017 - 07/2001
3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2009 - 07/2001
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 10/2001
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2008 - 01/2005
2	pro-brain natriuretic peptide (1-76)IBA 01/2008 - 01/2005
2	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2008 - 01/2005
2	HomocysteineIBA 04/2006 - 01/2002
2	Insulin (Novolin)FDA Link 01/2002 - 03/2000
1	oxidized low density lipoproteinIBA 01/2017
1	Vitamin K FDA Link 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Prothrombin (Factor II)IBA 06/2015
1	LeptinIBA 11/2010
1	Anticardiolipin AntibodiesIBA 06/2010
1	AcidsIBA 06/2010
1	Messenger RNA (mRNA)IBA 06/2010
1	beta 2-Glycoprotein I (Apolipoprotein H)IBA 06/2010
1	Antiphospholipid AntibodiesIBA 06/2010
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2009
1	Endothelin-1 (Endothelin 1)IBA 01/2005
1	AnticoagulantsIBA 08/2003
1	fibrin fragment D (D-dimer)IBA 08/2003
1	Fumigant 93 (D-D)IBA 08/2003
1	Immunoglobulin A (IgA)IBA 04/2003
1	Triglycerides (Triacylglycerol)IBA 09/2002
1	LDL CholesterolIBA 09/2002
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2002
1	PharmavitIBA 03/2001

3	Therapeutics 01/2017 - 04/2003
2	Secondary Prevention 08/2016 - 10/2004
1	Parenteral Nutrition 04/2011
1	Renal Dialysis (Hemodialysis) 04/2003